Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Oncology . These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114805367A discloses novel triazolopyrimidine derivatives with potent USP28 inhibitory activity, offering a scalable route for high-purity pharmaceutical intermediate manufacturing.
Patent CN111057729A details a green enzymatic route for Larotretinib intermediates, offering high ee values and cost reduction in API manufacturing.
Patent CN116354976A reveals a novel binary solvent purification method for camptothecin derivatives, achieving over 99% purity without column chromatography for reliable supply.
Patent CN113135884B discloses catalyst-free synthesis of isochromene derivatives. Discover cost-effective routes for high-purity SIRT inhibitors and metabolic disease drug intermediates.
Patent CN1075718A reveals a novel metal alkoxide route for Taxol synthesis, offering high stereoselectivity and cost reduction in API manufacturing for global supply chains.
Patent CN100368373C details a novel synthesis for carboxyl-substituted resveratrol analogs with superior antitumor activity, offering scalable manufacturing and cost-effective production for pharmaceutical applications.
Novel synthesis of benzimidazole compound (I) via late-stage Suzuki coupling. Reduces cost and improves scalability for oncology intermediates.
Patent CN102351870A reveals a novel benzacridine synthesis route targeting c-myc DNA, offering scalable production and cost-effective API intermediate manufacturing solutions.
Patent CN109575109B reveals a novel fragment condensation method for Degarelix, offering significant cost reduction and high purity for reliable peptide API supply chains.
Patent CN101712708A reveals a scalable Decitabine synthesis using pivaloyl protection, eliminating chromatography for significant cost reduction and high purity.
Patent CN110950914A reveals a highly selective iridium complex synthesis. Discover cost-effective manufacturing routes for potent cervical and ovarian cancer therapeutics.
Patent CN104177478B details a safer Fmoc-based peptide synthesis route achieving over 99% purity. This method enables cost reduction in API manufacturing through improved safety.
Patent CN111875591B details a green one-pot synthesis for benzopyrone intermediates using recyclable ionic liquids, offering significant cost and purity advantages for pharmaceutical manufacturing.
Patent CN110981800A reveals a novel low-temperature route for Lenvatinib intermediates using ZnO catalysis, offering significant cost reduction and supply chain reliability for pharma manufacturing.
Patent CN106831793B reveals high-yield Beckmann rearrangement for ovarian cancer drug intermediate ensuring cost reduction and supply chain reliability for global pharmaceutical manufacturing.
Advanced synthesis methods for c-Met inhibitors reduce costs and improve supply chain reliability for pharmaceutical intermediates globally.
Patent CN112979662A details a transition-metal-free acetoxylation route. This breakthrough offers cost reduction in pharmaceutical intermediate manufacturing with high purity.
Discover novel pyrimidine derivatives via Suzuki coupling. Enhance your pipeline with high-purity intermediates and cost-effective manufacturing solutions.
Patent CN112457293B reveals a high-yield TBTU/DBU method for Lorlatinib, offering significant cost and purity advantages for pharmaceutical manufacturing.
Discover advanced synthesis routes for 3,4,5-trisubstituted isoxazoles with potent antitumor activity. Optimized for scalable API manufacturing and cost-effective procurement.